Literature DB >> 7998946

Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells.

S Zhang1, J D McCarter, Y Okamura-Oho, F Yaghi, A Hinek, S G Withers, J W Callahan.   

Abstract

Chinese hamster ovary cell clones permanently transfected with the cDNA for human lysosomal beta-galactosidase secrete the enzyme precursor into the cell medium, from which it is purified to apparent homogeneity in a single step by affinity chromatography. The purified precursor is fully active, displays the same pH optimum and Km values as the mature placental enzyme, and has an intact C-terminus. The intact enzyme when chromatographed on a Sephacryl S-200 molecular-sieve column elutes as a 105,500 Da monomer, whereas on SDS/PAGE gels the polypeptide migrates as an 88 kDa polypeptide. A time course of digestion with glycopeptide-N-glycanase shows the gradual conversion of the precursor from an 88 to a 72 kDa protein, suggesting the presence of five N-linked oligosaccharides in the protein. The precursor is readily taken up in a mannose-6-phosphate-dependent manner into beta-galactosidase-deficient, GM1-gangliosidosis fibroblasts, and the enzyme activity is returned to normal levels. We show that the stereochemical course of enzymic hydrolysis involves the retention of the beta-configuration at the anomeric centre, suggesting a double-displacement mechanism. Furthermore, the enzyme is rapidly and irreversibly inactivated in the presence of the mechanism-based inactivator 2,4-dinitrophenyl-2-deoxy-2-fluoro-beta-D-galactopyranoside, which implicates a covalent intermediate. The enzyme is also inactivated by 1-ethyl-3(3-dimethylamino-propyl)carbodi-imide and by phenylglyoxal, which implicates carboxylate and arginine residues respectively in the active site. We conclude that the beta-galactosidase precursor is functionally identical to the mature lysosomal form of the enzyme and serves as an excellent enzyme source for investigation of structure-function relationships in the protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998946      PMCID: PMC1137483          DOI: 10.1042/bj3040281

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Direct 1H n.m.r. determination of the stereochemical course of hydrolyses catalysed by glucanase components of the cellulase complex.

Authors:  S G Withers; D Dombroski; L A Berven; D G Kilburn; R C Miller; R A Warren; N R Gilkes
Journal:  Biochem Biophys Res Commun       Date:  1986-09-14       Impact factor: 3.575

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Stoichiometry of the human lysosomal carboxypeptidase-beta-galactosidase complex.

Authors:  A V Pshezhetsky; M Potier
Journal:  Biochem Biophys Res Commun       Date:  1993-08-31       Impact factor: 3.575

5.  Purification of acid beta-galactosidase and acid neuraminidase from bovine testis: evidence for an enzyme complex.

Authors:  F Verheijen; R Brossmer; H Galjaard
Journal:  Biochem Biophys Res Commun       Date:  1982-09-30       Impact factor: 3.575

6.  Indigogenic methods for glycosidases. II. An improved method for beta-D-galactosidase and its application to localization studies of the enzymes in the intestine and in other tissues.

Authors:  Z Lojda
Journal:  Histochemie       Date:  1970

7.  The relation between human lysosomal beta-galactosidase and its protective protein.

Authors:  A T Hoogeveen; F W Verheijen; H Galjaard
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

8.  Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.

Authors:  A D'Azzo; A Hoogeveen; A J Reuser; D Robinson; H Galjaard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein.

Authors:  F W Verheijen; S Palmeri; A T Hoogeveen; H Galjaard
Journal:  Eur J Biochem       Date:  1985-06-03

10.  Human placental beta-galactosidase: structural and immunological observations.

Authors:  C S Jones; D Mahuran; J A Lowden; J W Callahan
Journal:  Can J Biochem Cell Biol       Date:  1984-06
View more
  16 in total

1.  Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.

Authors:  S Zhang; R Bagshaw; W Hilson; Y Oho; A Hinek; J T Clarke; J W Callahan
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.

Authors:  A Hinek; S E Wilson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Thioglycoligase-based assembly of thiodisaccharides: screening as beta-galactosidase inhibitors.

Authors:  Young-Wan Kim; Hong-Ming Chen; Jin Hyo Kim; Johannes Müllegger; Don Mahuran; Stephen G Withers
Journal:  Chembiochem       Date:  2007-09-03       Impact factor: 3.164

4.  Generation and characterization of recombinant feline beta-galactosidase for preclinical enzyme replacement therapy studies in GM1 gangliosidosis.

Authors:  Tatiana I Samoylova; Douglas R Martin; Nancy E Morrison; Misako Hwang; Anna M Cochran; Alexandre M Samoylov; Henry J Baker; Nancy R Cox
Journal:  Metab Brain Dis       Date:  2008-04-18       Impact factor: 3.584

5.  Low p16INK4a Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone.

Authors:  Mindy Kim Graham; Lorenzo Principessa; Lizamma Antony; Alan K Meeker; John T Isaacs
Journal:  Prostate       Date:  2016-11-08       Impact factor: 4.104

6.  Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.

Authors:  Umeharu Ohto; Kimihito Usui; Toshinari Ochi; Kenjiro Yuki; Yoshinori Satow; Toshiyuki Shimizu
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

7.  L-asparaginase of Thermus thermophilus: purification, properties and identification of essential amino acids for its catalytic activity.

Authors:  A A Pritsa; D A Kyriakidis
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

8.  Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.

Authors:  A Hinek; S Zhang; A C Smith; J W Callahan
Journal:  Am J Hum Genet       Date:  2000-06-06       Impact factor: 11.025

9.  Modulating action of the new polymorphism L436F detected in the GLB1 gene of a type-II GM1 gangliosidosis patient.

Authors:  Anna Caciotti; Tiziana Bardelli; John Cunningham; Alessandra D'Azzo; Enrico Zammarchi; Amelia Morrone
Journal:  Hum Genet       Date:  2003-03-19       Impact factor: 4.132

10.  Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.

Authors:  Douglas R Martin; Brigitte A Rigat; Polly Foureman; G S Varadarajan; Misako Hwang; Barbara K Krum; Bruce F Smith; John W Callahan; Don J Mahuran; Henry J Baker
Journal:  Mol Genet Metab       Date:  2008-03-18       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.